A detailed history of Sbi Securities Co., Ltd. transactions in Pro Phase Labs, Inc. stock. As of the latest transaction made, Sbi Securities Co., Ltd. holds 404 shares of PRPH stock, worth $96. This represents 0.0% of its overall portfolio holdings.

Number of Shares
404
Holding current value
$96
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 05, 2025

BUY
$0.61 - $2.47 $246 - $997
404 New
404 $306,000

Others Institutions Holding PRPH

About ProPhase Labs, Inc.


  • Ticker PRPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 16,024,400
  • Market Cap $3.85M
  • Description
  • ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Lege...
More about PRPH
Track This Portfolio

Track Sbi Securities Co., Ltd. Portfolio

Follow Sbi Securities Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sbi Securities Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Sbi Securities Co., Ltd. with notifications on news.